Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-11-004052

Sr. VP, Drug Development sold 18,270 shares at $5.23 ($95,552)

  • Sr. VP, Drug Development acquired 6,844 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koya Keizo Sr. VP, Drug Development 2011-03-01 Sale −18,270 $5.23 $95,552 32,999 D
Koya Keizo Sr. VP, Drug Development 2011-03-01 Grant or award +6,844 39,843 D
Derivatives
Koya Keizo Sr. VP, Drug Development 2011-03-01 Grant or award · Employee Stock Option (Right to Buy) +58,200 58,200 D
Open-market sales · 18,270 sh · avg $5.23 · $95,552
Loading xslF345X03/edgar.xml…